supported by grants from the National Mega Research Program of China(No.2008ZX10002-011);the National Key Basic Research Program of China(No.2005CB 522901,2007CB512804,2009CB522500);the National Natural Science Foundation of China(No.30571646);Deutsche Forschungsgemeinschaft(TRR60)to Dong-liang YANG
Long-term compliance with regular surveillance is important for the prevention and timely management of chronic hepatitis B (CHB). However, there are no researches focusing on the compli- ance of hepatitis B virus i...
National Science Fund of China(NSFC)(30571643,30672380,30700702);National Key Basic Research Program of China(2005CB522901,2007CB512900)
Previous study on TNFRl-mediated hepatocyte apoptosis has been implicated in the development of fulminant viral hepatitis. To interfere with the potentially effective target, plasmid named p-mTNFRlshRNA complimentary ...
the National Key Basic Research Program of China (2007CB512900, 2005CB522901, 2005CB 522507);the National Science Fund of China (NSFC 30672380, 30571643)
The role of chemokines in murine hepatitis virus strain 3 (MHV-3) induced fulminant hepatic failure (FHF) is not well defined. In this study, we investigated the role of the CXC chemokine receptor 3 (CXCR3)- associate...
supported by grants from the National Key Basic Research Program of China (No.20014CB510008,No.2005CB522901);the National Natural Sciences Foundation of China (No.30400412)
Hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTLs) are believed to play a major role in viral clearance and disease pathogenesis during HBV infection. To clarify the differences in host immune respons...
The Natural Science Foundation of China,NSFC (30672380,30571643);National Key Basic Research Program of China (2007CB512900,2005CB522901,2005CB522507);11th Five-Year Plan Key Project (2006BAI05A07)
AIM: To examine the role of Fibrinogen-like protein 2 (fgl2)/fibroleukin in tumor development. Fgl2 has been reported to play a vital role in the pathogenesis in MHV-3 (mouse hepatitis virus) induced fulminant an...